Sulfasalazine-induced myopathy in a patient with an acute spondyloarthritis

Intern Med J. 2022 Jan;52(1):155. doi: 10.1111/imj.15654.

Authors

Hugh C Caterson¹, Peter Youssef^{1

2}

Affiliations

¹ Rheumatology Department, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
² Department of Medicine, University of Sydney, Sydney, New South Wales, Australia.

PMID: 35060279
DOI: 10.1111/imj.15654

No abstract available

Publication types

Letter

MeSH terms

Antirheumatic Agents* / adverse effects
Humans
Muscular Diseases*
Spondylarthritis* / drug therapy
Sulfasalazine / adverse effects

Substances

Antirheumatic Agents
Sulfasalazine